Indegene and SynPhNe join hands to bring relief to stroke and TBI victims worldwide
PRINCETON, N.J. and SINGAPORE, May 16, 2023 (GLOBE NEWSWIRE) -- Indegene, a digital-first, life sciences commercialization company, announced today that it is joining hands with SynPhNe, to bring their Synergistic Physio-Neuro Platform to market.
SynPhNe has developed the world’s first connected wearable solution that trains brain and muscle in one system. It is designed to help stroke survivors and patients with disabilities recover and lead more independent lives. This device is backed by ten years of clinical studies and provides a wide range of care programs that can address the key challenges of rehabilitation and recovery from neurological conditions including stroke and traumatic brain injuries (TBI), learning disabilities, the effects of aging, chronic stress, and pain.
SynPhNe uses a real-time neuroplasticity training model to help the body and brain recover function together. Real-time, synchronized EEG and EMG signals are captured during tasks and activities to create a self-correcting learning loop, making it possible to self-administer physical therapy, occupational therapy, and neuro therapy protocols at home, after initial training with a therapist.
Both the stroke and TBI markets are growing rapidly. Currently, the stroke management industry is estimated to be over $37 billion, and it is projected to reach more than $59 billion by 20321. More than 6 million people worldwide each year are pegged as stroke survivors. The traumatic brain injury market is also growing with more than 69 million people worldwide sustaining a TBI each year2.
Sabi Bivas, President of SynPhNe Health, Inc., said “More people are being impacted by neurological conditions each year. To help them get better access to effective treatment, we are excited to work with Indegene to bring our treatment option to the market. Indegene’s focus on technology and providing future-ready healthcare aligns with our mission. We will leverage their modern commercialization model to try and bring relief to many more people around the world suffering from strokes, TBIs, and other neurological conditions.”
Timothy Moore, Senior Vice President, Emerging Biotech and Key Accounts, Indegene, said, “We are excited to join hands with SynPhNe to support their early commercialization and bring this device to market. We will use our modern go-to-market model to drive pricing strategy and develop a strategic launch plan that coordinates education and marketing efforts based on our deep expertise in market research and brand planning.”
SynPhNe™ is a Singapore-based company that has designed the world’s first wearable solution which trains brain and muscle in one system. It is designed to help restore movement, cognition, and function in patients after stroke and other neurology-related disorders. Their device gives patients a platform to take charge of their own rehabilitation in real-time. Whether a patient is coping with a disability from stroke or experiencing the first signs of aging, SynPhNe is an award-winning technology that has empowered people worldwide to live more fulfilled lives. To learn more, please visit www.synphne.com
We are a digital-first, life sciences commercialization company. We help biopharmaceutical, emerging biotech and medical device companies develop products, get them to the market, and grow their impact through the life cycle in a more effective, efficient, and modern way. We bring together healthcare domain expertise, fit-for-purpose technology, and an agile operating model to provide a diverse range of solutions. These aim to deliver, amongst other outcomes, a personalized, scalable and omnichannel experience for patients and physicians. It’s what drives our team and our purpose to enable healthcare organizations to be future ready. To learn more, please visit www.indegene.com
For media inquiries, please contact:
Sabi Bivas | Sabi@synphne.com
Yadunandan K V | email@example.com
1Stroke Management Market Share Statistics Report 2023-2032 (gminsights.com)
2Traumatic brain injury: Statistical data on recovery and mortality (tbi.com)To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Sandoz plans move to new central Basel headquarters by mid-2024, following proposed spin-off as standalone company1.6.2023 07:15:00 CEST | Press release
Sandoz AG to remain based in Basel, Switzerland following proposed spin-off from Novartis Announcement of planned city-center HQ marks important milestone as Sandoz prepares to become independent company Basel, as a global life sciences center, ideally located to attract top talent Basel, June 1, 2023 — Sandoz AG, a global leader in generic and biosimilar medicines, has announced the location of its future permanent headquarters in central Basel. The Sandoz AG headquarters plans to move to a landmark office building called “Elsässertor” in the center of Basel, right by the Basel SBB train station. Sandoz expects to move from the Novartis Campus to its new headquarters in mid-2024. The announcement confirms the Sandoz commitment to Basel following its proposed separation from Novartis in the second half of 2023. Sandoz CEO Richard Saynor says: “I’m delighted to confirm that we will continue to call Basel home. This is an important milestone on our way to becoming an independent company.
FLSmidth to expand mill liner capacity through acquisition of Morse Rubber1.6.2023 07:01:00 CEST | Press release
PRESS RELEASE 1 June 2023, Copenhagen, Denmark FLSmidth has, per 1 June 2023, acquired the American company Morse Rubber. Based in Iowa, Morse Rubber manufactures and markets specialised, heavy-duty rubber products for mineral processing, among others. Morse Rubber was formed more than three decades ago and has 23 employees. All employees will be transferred to FLSmidth as part of the acquisition. This acquisition fully supports FLSmidth Mining’s CORE´26 strategy, which includes targeting service growth through strategic investments and prioritisation. As the global market leader in large grinding mills, FLSmidth has a clear ambition of strengthening its service offerings around these products, especially for mill liners where FLSmidth has been capacity constrained in some regions. The Morse Rubber competences will be adding advanced molding capabilities for rubber and composite mill liners, as well as screen media and various rubber and rubber ceramic wear components, to the existing
DFDS launches new Initiative to Protect Sperm Whales in Southern Greece1.6.2023 07:00:00 CEST | Press release
At DFDS, our awareness of how our ferry and logistics activities impact biodiversity is growing. We are taking essential steps to protect marine life in the Mediterranean around the Southern part of Greece, a critical habitat for endangered sperm whales. Sofie Lindegaard, Head of Group Sustainability, explains, "Our responsibility to the marine life in the waters we operate is crucial. We want to ensure that our operations respect the different ecosystems." "Working closely with NGOs is an invaluable way to get insights into important and sometimes unknown areas and constructive input on how to address it," Sofie adds. Together with a coalition of NGOs, including IFAW, Ocean Care, Pelagos Cetacean Institute, and WWF Greece, DFDS has developed initiatives to reduce vessel-whale collisions in the Hellenic Trench in Southern Greece: Route Adjustments: We have redefined our vessel routes to avoid high-risk areas known for frequent sperm whale sightings. Slow Steaming: We have limited vesse
DFDS omlægger ruter og sænker farten for at beskytte kaskelothvaler i det sydlige Grækenland1.6.2023 07:00:00 CEST | pressemeddelelse
I tæt samarbejde med en række NGO’er har DFDS taget væsentlige skridt for at beskytte havlivet i Middelhavet i Den Hellenske Grav i det sydlige Grækenland, et kritisk habitat for truede kaskelothvaler. Initiativerne skal mindske risikoen for kollisioner mellem skibe og hvaler. Ændringerne består af: Rutejusteringer: DFDS har justeret sine skibsruter for at undgå højrisikoområder kendt for hyppige observationer af kaskelothvaler.Lavere fart: DFDS har begrænset skibenes hastighed i disse højrisikozoner for at minimere potentialet for kollisioner.Øget overvågning og melding: DFDS har indført en politik, der opfordrer alle kaptajner til at være årvågne, identificere hvaler og hurtigt kommunikere observationer til DFDS' skibe og andre skibe i nærheden. "Vi er bevidste om at vores færgeaktiviteter kan have en påvirkning af biodiversiteten og føler et stort ansvar over for havlivet i de farvande, vi opererer i. Vi ønsker at sikre, at vores operationer respekterer de forskellige økosystemer,"
Aktias placeringsutsikt: Ränteplaceringar har gjort comeback, utsikterna för aktiemarknaden är osäkra1.6.2023 07:00:00 CEST | Pressemelding
Pressmeddelande Aktia Abp 1.6.2023 kl. 8.00 På placeringsmarknaden har år 2023 börjat i positiva tecken. I mitten av maj hade den globala aktiemarknaden avkastat cirka7 procent och räntemarknaden mellan0 och 4,5procent. Ränteplaceringar har gjort en snabb comeback och fungerar igen som ett skyddande element i portföljer med omfattande diversifiering. Aktia skriver i sin färska placeringsutsikt att det här året kommer att bli intressant för placeraren. De skador som kriget i Ukraina och inflationschocken orsakade utvecklingen förra året har korrigerats aktiemarknaden – utvecklingen har varit till och med överraskande positiv. Det i huvudsak positiva sentimentet har stött sig på den starka konsumentdrivna ekonomiska tillväxten och på att resultatutvecklingen har stått sig bättre än väntat. När det gäller aktier beräknas tillväxttakten avta eller till och med stanna upp helt under resten av året. För en allokeringsplacerare som utnyttjar olika tillgångsslag i sin placeringsverksamhet har